Quest Magazine

Live Stream of MDCC Meeting Shows Advocacy in Action

Want to spend Monday watching advocacy in action advancing the cause of muscular dystrophy research?

Becker MD Conference Can Be Attended Online Aug. 24

MDA and John Hopkins Medicine will present the 2013 national Becker Muscular Dystrophy Conference Saturday, August 24, in Baltimore. Free to all participants with BMD and their family and friends, the conference can be attended in person or online.

MDA's 'Bridge-to-Industry' Program Awards Second Grant

Christopher Penton recently completed his doctorate (Ph.D.) in integrated biomedical sciences at Ohio State University in Columbus.

MDA Awards $8.5 Million to 31 Neuromuscular Disease Research Projects

In its summer 2013 round of research grant awards, the Muscular Dystrophy Association aims to catalyze research progress in a dozen neuromuscular diseases, with an eye toward applying that knowledge to related muscle diseases, as well.

“A large number of our grants are investigating new therapeutic technologies,” notes Jane Larkindale, MDA's vice president of research. “These are 'platform' technologies, where successes can be transferred well beyond the specific disease in which they are developed and tested.”

New MDA Grants Examine Protein Misfolding in ALS

MDA’s latest round of ALS research grants focuses on basic mechanisms in the disease process, with an emphasis on targeting misfolded proteins such as TDP43, FUS and SOD1.

DMD: Exon-Skipping Drug Drisapersen Appears to Increase Dystrophin Levels

Multinational pharmaceutical company GlaxoSmithKline (GSK) has released encouraging results about dystrophin protein production in a phase 2, non-U.S. trial of its exon-skipping compound drisapersen in boys with Duchenne muscular dystrophy (DMD).

MDA Funds Study of Prednisone in Very Young Boys with DMD

Pediatric neurologist Anne Connolly has received an MDA grant to study the effects of prednisone on Duchenne muscular dystrophy in very young children.

MMD1: Abnormalities Found in PKM Enzyme

An abnormality in a muscle enzyme known as pyruvate kinase (PKM) has been added to the list of things that go wrong in type 1 myotonic muscular dystrophy (MMD1, or DM1), a new study has found.

MDA supported Thomas Cooper at Baylor College of Medicine in Houston on this study, which was published online in Proceedings of the National Academy of Sciences July 30, 2013.

National ALS Biorepository Pilot Study Launched

ALS Briefs: Stem Cells, Risk Factors, Emotion Processing Abnormalities

This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

Pages